RESEARCH SPOTLIGHT: Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia
Centricity Research’s Chief Medical officer Dr. Ronnie Aronson shares…
RESEARCH SPOTLIGHT: Reproducibility in the cardiometabolic responses to high-intensity interval exercise in adults with type 1 diabetes
With one month of 2019 already completed, we are excited to share a 2nd FIT…
RESEARCH SPOTLIGHT: Optimal Insulin Correction Factor in Post–High-Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes: The FIT Study
On Monday November 19th, Centricity Research’s own Type 1 Diabetes &…